Please login to the form below

Not currently logged in
Email:
Password:

life science

This page shows the latest life science news and features for those working in and with pharma, biotech and healthcare.

Google boosts healthcare business with new hire

Google boosts healthcare business with new hire

Earlier this year, Google’s life science and healthcare division Verily teamed up with Gilead to develop a high-res molecular map of inflammatory diseases.

Latest news

  • Brexit to blame as firm plans to leave UK for Ireland Brexit to blame as firm plans to leave UK for Ireland

    This includes the life sciences sector – but Steris has joined a handful of firms looking to remain in the EU and opting to relocate. ... Brexit. The UK government life science leaders have hinted that there are a number of companies waiting to

  • UK science could be 'crippled' by a hard Brexit UK science could be 'crippled' by a hard Brexit

    Nurse added: Science and research matter for the UK’s economic growth, for the nation’s health and quality of life, and for the environment. ... Nevertheless, the ABPI's Mike Thompson recently warned that even the existing draft transition deal

  • UK pharma leader warns on ‘untenable’ Brexit deal UK pharma leader warns on ‘untenable’ Brexit deal

    This sets out a framework for future relations, but Thompson revealed for the first time that the ABPI viewed this as a major step backwards for the life science sector.

  • UK government’s low-skill migration plans ‘will hit social care’ UK government’s low-skill migration plans ‘will hit social care’

    Post-Brexit, the UK’s immigration system must be needs-based, build on the UK’s strong academic science base, and support the UK life sciences sector to flourish.”.

  • Collaborate to survive Collaborate to survive

    Collaborate to survive. The pharma and life sciences industries are being buffeted by major shifts in technology, data, funding, demographics and patient expectations – all happening at the same time. ... many powerful changes converged, he says,

More from news
Approximately 7 fully matching, plus 308 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 67 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Industry round up: appointments. Destiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams. ... Sir Nigel Rudd, chairman of Destiny Pharma, said: “Rodgers’experience of guiding growth companies, and in particular those in the

  • Kevin Sin joins GSK Kevin Sin joins GSK

    Sin joins GSK from Genetech, where he served as vice president and global head of oncology business development and has worked within the pharmaceutical and life science industry for over 20 ... Gaining access to the best science and technologies across

  • Lars Rebien Sørensen becomes chairman of Novo Holdings Lars Rebien Sørensen becomes chairman of Novo Holdings

    He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global life science sector. ... I consider it to be a great responsibility to lead the continued growth of Novo Holdings as it plans to further

  • Building trust in our industry Building trust in our industry

    The other sectors (hospitals/clinics, health insurance, consumer health and biotech/life science) have all gained trust with hospitals/clinics leading the charge with a nine-point increase since 2015, reaching

  • Pegasus bolsters team Pegasus bolsters team

    Following its expansion of its Macclesfield office last year, Pegasus, part of UDG Healthcare, has grown its pharma and life science division by appointing six new hires. ... Coming from Ashfield Healthcare Communications’sister agency Zoetic Science

More from appointments
Approximately 0 fully matching, plus 96 partially matching documents found.

Latest from PMHub

  • Life Sciences 4.0 - Antony Rawlins

    Life Sciences 4.0 - Antony Rawlins.

  • Random42 exhibiting at BIO-Europe 2018

    The 24. th. annual international event is Europe’ s largest life science partnering conference and is expected to draw over 4, 000 industry attendees for three days of high level networking,

  • Random42 Exhibiting at BioCap Conference 2018

    Now in its seventh year, the BioCap Conference is the only specialist life science investment and showcase conference in the North of England and is aimed at highlighting the wealth of ... life science investment opportunities.

  • Patient Engagement for the Life Sciences

    It presents the compelling argument for why life science companies need to embrace and partner with patients and outlining an operating framework for doing it effectively. ... for the Life Sciences.To celebrate the book launch, we’ ve been talking to

  • Moving away from pharma’s paternalistic approach

    11 September 2018, Cambridge, UK— The pharmaceutical industry has achieved great success in delivering innovative medicines, but life science companies must become ever more consumer-centric if they are to realise ... They are co-founders of MediPaCe,

More from PMHub
Approximately 2 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics